Rapid Communication|
Open Access
|Issue|Published: 10 April 2023
Hypermethylation of the ALOX12 and CBS promoters in osteoporosis: Potential biomarkers for early diagnosis
Show Author's Information
Hide Author's Information
Shang Guoa,,1, Yue Wub,1, Weekai Chiaa,1, Peichun Hsua, Hongwei Wangc, Yunliang Wangd(
), Biao Zhonga,#(
)
Department of Orthopedic Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China
Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai 200025, China
The University of Chicago, Department of Medicine, Chicago, IL 60637, USA
Department of Neurology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450014, China
Peer review under responsibility of Chongqing Medical University.
1 These authors contributed equally to this work.
# Lead contact.
Cite this article:
Guo S, Wu Y, Chia W, et al. Hypermethylation of the ALOX12 and CBS promoters in osteoporosis: Potential biomarkers for early diagnosis. Genes & Diseases, 2024, 11(1): 30-33. https://doi.org/10.1016/j.gendis.2023.03.005